Sort   by:  
 Page size 
ProteomicsLipid nanoparticles improves ex vivo gene editing of human hematopoietic cells
Ex-vivo gene editing in T cells and hematopoietic stem/progenitor cells (HSPCs) holds promise for treating diseases by non-homologous end joining (NHEJ) gene disruption or homology-driven repair (HDR) gene correction. Gene editing encompasses delivery of nucleases by electroporation and, when aiming...
ORGANISM(S): Homo sapiens (Human) 
2024-01-26 | PXD037529 | Pride
Hunan Nanoparticles Hematopoietic cells 
UnknownMuscle synergies in upper limb stroke rehabilitation: a scoping review.
Not available
S-EPMC11558461 | biostudies-literature
UnknownH-Ferritin-nanocaged olaparib: a promising choice for both BRCA-mutated and sporadic triple negative breast cancer.
Not available
S-EPMC5548799 | biostudies-literature
UnknownBaseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study.
Not available
S-EPMC7998451 | biostudies-literature
UnknownSynthesis and biological activity evaluation of 3-(hetero) arylideneindolin-2-ones as potential c-Src inhibitors.
Not available
S-EPMC9448371 | biostudies-literature
UnknownMulticentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX).
Not available
S-EPMC11794632 | biostudies-literature
UnknownEffects of robotic upper limb treatment after stroke on cognitive patterns: A systematic review.
Not available
S-EPMC9837692 | biostudies-literature
UnknownEfficacy and tolerability of low versus standard daily doses of antiseizure medications in newly diagnosed focal epilepsy. A multicenter, randomized, single-blind, non-inferiority trial (STANDLOW).
Not available
S-EPMC12014934 | biostudies-literature
UnknownGastrointestinal involvement in very early and established systemic sclerosis: insights from the SPRING-SIR national Italian registry.
Not available
S-EPMC12862390 | biostudies-literature
UnknownLacosamide is Associated with a Higher Treatment Persistence at 12 Months than Brivaracetam and Perampanel Despite Similar Efficacy.
Not available
S-EPMC12804576 | biostudies-literature
Sort   by:  
 Page size